CDC. 2001a. New asthma estimates: Tracking prevalence, health care, and mortality. Available on the web at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm

CDC. 2001b. Self-reported asthma prevalence among adults—United States, 2000. MMWR Morb Mortal Wkly Rep 50(32):682–686.

CDC. 2001c. Vaccinia (Smallpox) Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 50(RR-10):1–25.

CDC. 200 1d. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2001; 50(RR-4);1–4.

Chan CC, Mochizuki M. 1999. Sympathetic ophthalmia: An autoimmune ocular inflammatory disease. Springer Semin Immunopathol. 21:125–134.

Chazono M, Hirota T, Yoshida I, Konobe T, Takaku K, Fukai K. 1991. Safety followup in a cohort of Biken acellular DPT vaccine recipients in Japan. Dev Biol Stand. 73:323–327.

Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK. 2001. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol. 2:1067–1076.

Chen RT, Pless R, Destefano F. 2001. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun. 16:309–318.

Cherry JD. 1998. Measles Virus. Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 4 ed. Philadelphia: WB Saunders.

Classen DC, Classen JB. 1997. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infectious Diseases in Clinical Practice 6(7):449–454.

Classen JB. 1996. Childhood immunization and diabetes mellitus. N Z Med J. 109:195.

Classen JB, Classen DC. 1996. Vaccines modulate IDDM. Diabetologia. 199639:500–502.

Classen JB, Classen DC. 1999. Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity. 31:43–45.

Communicable Disease Report. 2001. MMR vaccination coverage in the United Kingdom. Communicable Disease Report CDR Weekly. 11(4).

Constantinescu CS, Wysocka M, Milliard B, Ventura ES, Lavi E, Trinchieri G, Rostami A. 1998. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol. 161:5097–5104.

Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 13:470–511.

Dagan R, Eskola J, Leclerc C, Leroy O. 1998. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 66(5):2093–2098.

Dahlquist G, Gothefors L. 1995. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia. 38:873–874.

Daniel T, Bates JH, Downes K. 1994. History of Tuberculosis. Bloom BR, ed. Tuberculosis: Pathogenesis, Protection, and Control.Washington, DC: ASM Press. Pp. 13–24.

Davidson A, Diamond B. 2001. Autoimmune diseases. N Engl J Med. 345:340–350.

Davidson M, Letson GW, Ward JI, Ball A, Bulkow L, Christenson P, Cherry JD. 1991. DTP immunization and susceptibility to infectious diseases. Is there a relationship? Am J Dis Child. 145:750–754.

Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG, Sarfati M. 1998. Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine. 16:1415– 1419.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K. 2001. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus . Pediatrics. 108:E112.

Dorman JS, McCarthy BJ, O’Leary LA, Koehler AN. 1995. Risk Factors for Insulin-Dependent Diabetes. National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda MD: National